Page 7 - Pfizer

Pfizer to pay $11.6 bn for Biohaven Pharmaceutical to tap migraine market

Pfizer will pay $148.50 a share for all of New Haven, Connecticut-based Biohaven's outstanding stock, according to a statement Tuesday

Pfizer sets up drug development centre at Chennai's IIT Research Park

The centre integrates two essential functions under the export-oriented undertaking of Pfizer: Pharmaceutical Sciences (PharmSci) and Global Technology and Engineering (GT&E) Centre of Excellence.

Pfizer's profit grows by 61% in first qtr; company revises 2022 forecast

Sales of Pfizer's COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61per cent.

Pfizer stock falls as Covid pill fails in preventive therapy trial

The trial failure, along with reports of rebounding coronavirus levels in some patients who have completed a course of Paxlovid, are unlikely to change the drug's sales potential

'Hire me': Star Trek star, others ping Elon Musk for jobs at Twitter

'Hire me to run Twitter as VP of Product,' tweeted Nikita Bier, co-founder of a positivity-focused polling app called tbh that was acquired by Meta Platforms

Pfizer's anti-Covid pill Paxlovid could be available in India next week

This assumes significance as Covid cases are on the rise in the country, especially in the National Capital Region (NCR)

Pfizer to seek Covid-19 booster shots for healthy 5- to 11-year-olds in US

Now Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized shot

Indian Covid vaccines better than Pfizer, Moderna says Adar Poonawalla

Covid vaccines

'4th vaccine dose protects elderly from Covid but protection wanes quickly'

A 4th dose of Pfizer vaccine lowered rates of Covid-19 among people aged 60 years or older but protection against the infection appeared short-lived, according to a study conducted in Israel

US pulls GSK's Covid drug as omicron sibling dominates cases

GlaxoSmithKline's IV drug for Covid-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most US cases, federal health regulators said

FDA authorises second booster of Pfizer/BioNTech, Moderna Covid shots

FDA authorises another booster dose of the Pfizer or Moderna Covid vaccine for people age 50 and up

Strides Pharma Science signs pact with MPP to market Covid-19 drug

Branded as Kovidax, Strides' generic version of the Pfizer oral treatment will be launched in 95 markets as part of the sub-licensing agreement with Medicines Patent Pool (MPP), the drug firm said

Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug

Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.

Covid: China says vaccine makers upgraded shots to fight Omicron

Early lab studies have shown inactivated vaccines developed by Chinese companies Sinovac and Sinopharm elicited less protective antibodies against the omicron variant than mRNA vaccines from Pfizer

Moderna seeks FDA authorization for second Covid booster for all adults

Moderna Inc on late Thursday sought emergency use authorization with US health regulators for a second Covid booster shot, as a surge in cases in some parts of the world fuels fears of another wave

19 Indian companies sign licensing pact for Pfizer's oral Covid drug

Torrent Pharma and Cadila Pharma sign licensing agreement with MPP to make and market the drug

Cadila, Torrent get licence to make generic version of Pfizer's Covid pill

Pharma firms enter into licensing agreement with Medicine Patent Pool to use nirmatrelvir compound for making PAXLOVID

More than 30 companies to start manufacturing Pfizer's Covid pill

Generic drugmakers across a dozen countries in Asia, the Caribbean, the Middle East and Eastern Europe will begin producing either the raw ingredients for the Pfizer drug or the pill itself.

Pfizer seeking authorisation for 4th Covid dose for seniors: Report

Drugmaker Pfizer is expected to request authorisation this week for an additional Covid-19 booster dose for seniors, according to a person familiar with the matter.

Pfizer-BioNTech vax greatly reduces Omicron infection risk among kids: CDC

Two doses of Pfizer-BioNTech Covid-19 vaccine greatly reduced the risk of Omicron infection among children aged five to 15, according to a study published by the US CDC.